RISS 학술연구정보서비스

검색
다국어 입력

http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.

변환된 중국어를 복사하여 사용하시면 됩니다.

예시)
  • 中文 을 입력하시려면 zhongwen을 입력하시고 space를누르시면됩니다.
  • 北京 을 입력하시려면 beijing을 입력하시고 space를 누르시면 됩니다.
닫기
    인기검색어 순위 펼치기

    RISS 인기검색어

      KCI등재후보

      Dietary Lactose as a Potential Risk Factor for Coronary Heart Disease and Ovarian Cancer

      한글로보기

      https://www.riss.kr/link?id=A104886670

      • 0

        상세조회
      • 0

        다운로드
      서지정보 열기
      • 내보내기
      • 내책장담기
      • 공유하기
      • 오류접수

      부가정보

      다국어 초록 (Multilingual Abstract) kakao i 다국어 번역

      Lactose is a disaccharide consisting of a glucose and a galactose. Milk is a sole source of lactose in natural food. Lactase hydrolyzes lactose into glucose and galactose that are absorbed in the intestine and utilized by body. After the weaning, lactase activity declines. Therefore, the majority of the adults have hypolactasia. The prevalence is above 50% in South America, Africa, and Asia. Lactose is consumed much as cow milk-based food products. However, it has no special nutritional importance for adults even it is suspected as a dietary risk factor for coronary heart disease (CHD) and ovarian cancer. The aim of this study is to review the evidences and to propose the possible mechanisms about the relations between lactose intake and CHD and ovarian cancer. Epidemiological studies support the connection of lactose and CHD. Several mechanisms are suggested to elucidate this connection but calcium theory is the most plausible. Galactose has been known to be toxic to ovary. Galactose is suggested to induce ovarian cancer through hypergonadotropic hypogonadism. Some epidemiological data support this but others do not. The consumption of lactose or galactose can induce CHD and ovarian cancer, but more research should be needed to make sure of the relation between lactose and these diseases.
      번역하기

      Lactose is a disaccharide consisting of a glucose and a galactose. Milk is a sole source of lactose in natural food. Lactase hydrolyzes lactose into glucose and galactose that are absorbed in the intestine and utilized by body. After the weaning, lact...

      Lactose is a disaccharide consisting of a glucose and a galactose. Milk is a sole source of lactose in natural food. Lactase hydrolyzes lactose into glucose and galactose that are absorbed in the intestine and utilized by body. After the weaning, lactase activity declines. Therefore, the majority of the adults have hypolactasia. The prevalence is above 50% in South America, Africa, and Asia. Lactose is consumed much as cow milk-based food products. However, it has no special nutritional importance for adults even it is suspected as a dietary risk factor for coronary heart disease (CHD) and ovarian cancer. The aim of this study is to review the evidences and to propose the possible mechanisms about the relations between lactose intake and CHD and ovarian cancer. Epidemiological studies support the connection of lactose and CHD. Several mechanisms are suggested to elucidate this connection but calcium theory is the most plausible. Galactose has been known to be toxic to ovary. Galactose is suggested to induce ovarian cancer through hypergonadotropic hypogonadism. Some epidemiological data support this but others do not. The consumption of lactose or galactose can induce CHD and ovarian cancer, but more research should be needed to make sure of the relation between lactose and these diseases.

      더보기

      참고문헌 (Reference)

      1 Schach von Wittenau M, "Whole animal models in safety evaluation" 36 : 177s-182s, 1984

      2 Faber MT, "Use of dairy products, lactose, and calcium and risk of ovarian cancer-Results from a Danish case-control study" 51 : 454-464, 2012

      3 Wells WW, "The increased severity of atherosclerosis in rabbits on a lactose-containing diet" 68 : 541-549, 1959

      4 Petry KG, "The fundamental importance of human galactose metabolism: lessons from genetics and biochemistry" 14 : 98-102, 1998

      5 Gueguen L, "The bioavailability of dietary calcium" 19 : 119s-136s, 2000

      6 Scrimshaw NS, "The acceptability of milk and milk products in populations with a high prevalence of lactose intolerance" 48 : 1079-1159, 1988

      7 Karas-Kuzelicki N, "Synergistic effect of high lactase activity genotype and galactose-1-phosphate uridyl transferase (GALT) mutations on idiopathic presenile cataract formation" 41 : 869-874, 2008

      8 Moss M, "Survival trends, coronary event rates, and the MONICA project. Monitoring trends and determinants in cardiovascular disease" 354 : 862-, 1999

      9 Sinkeldam EJ, "Subchronic and chronic toxicity/carcinogenicity feeding studies with lactitol in rats" 11 : 165-188, 1992

      10 Fraser IS, "Resistant ovary syndrome and premature ovarian failure in young women with galactosaemia" 4 : 133-138, 1986

      1 Schach von Wittenau M, "Whole animal models in safety evaluation" 36 : 177s-182s, 1984

      2 Faber MT, "Use of dairy products, lactose, and calcium and risk of ovarian cancer-Results from a Danish case-control study" 51 : 454-464, 2012

      3 Wells WW, "The increased severity of atherosclerosis in rabbits on a lactose-containing diet" 68 : 541-549, 1959

      4 Petry KG, "The fundamental importance of human galactose metabolism: lessons from genetics and biochemistry" 14 : 98-102, 1998

      5 Gueguen L, "The bioavailability of dietary calcium" 19 : 119s-136s, 2000

      6 Scrimshaw NS, "The acceptability of milk and milk products in populations with a high prevalence of lactose intolerance" 48 : 1079-1159, 1988

      7 Karas-Kuzelicki N, "Synergistic effect of high lactase activity genotype and galactose-1-phosphate uridyl transferase (GALT) mutations on idiopathic presenile cataract formation" 41 : 869-874, 2008

      8 Moss M, "Survival trends, coronary event rates, and the MONICA project. Monitoring trends and determinants in cardiovascular disease" 354 : 862-, 1999

      9 Sinkeldam EJ, "Subchronic and chronic toxicity/carcinogenicity feeding studies with lactitol in rats" 11 : 165-188, 1992

      10 Fraser IS, "Resistant ovary syndrome and premature ovarian failure in young women with galactosaemia" 4 : 133-138, 1986

      11 Chen YT, "Reduction in oocyte number following prenatal exposure to a diet high in galactose" 214 : 1145-1147, 1981

      12 Kushi LH, "Prospective study of diet and ovarian cancer" 149 : 21-31, 1999

      13 Seely S, "Possible connection between milk and coronary heart disease: the calcium hypothesis" 54 : 701-703, 2000

      14 Seely S, "Possible connection between milk and coronary heart disease: the calcium hypothesis" 54 : 701-703, 2000

      15 Forges T, "Pathophysiology of impaired ovarian function in galactosaemia" 12 : 573-584, 2006

      16 Lig G, "Ovarian effects of a high lactose diet in the female rat" 45 : 185-192, 2005

      17 Strain JJ, "Milk consumption, lactose and copper in the aetiology of ischaemic heart disease" 25 : 99-101, 1988

      18 Webb PM, "Milk consumption, galactose metabolism and ovarian cancer (Australia)" 9 : 637-644, 1998

      19 Larsson SC, "Milk and lactose intakes and ovarian cancer risk in the Swedish Mammography Cohort" 80 : 1353-1357, 2004

      20 Arola H, "Metabolism of lactose in the human body" 202 : 21-25, 1994

      21 Stone PM, "Massey LK Effect of dietary and infused lactose on rat intestinal lymph lipids" 31 : 170-178, 1987

      22 Vesa TH, "Lactose intolerance" 19 : 165s-175s, 2000

      23 Buller HA, "Lactose intolerance" 41 : 141-148, 1990

      24 Herrinton LJ, "Lactose and galactose intake and metabolism in relation to the risk of epithelial ovarian cancer" 141 : 407-416, 1995

      25 Meloni GF, "Lactose absorption in patients with ovarian cancer" 150 : 183-186, 1999

      26 Cramer DW, "Lactase persistence and milk consumption as determinants of ovarian cancer risk" 130 : 904-910, 1989

      27 Jyothi M, "Influence of galactose cataract on erythrocytic and lenticular glutathione metabolism in albino rats" 59 : 287-290, 2011

      28 Fathalla MF, "Incessant ovulation--a factor in ovarian neoplasia?" 2 : 163-, 1971

      29 Segall JJ, "Hypothesis: is lactose a dietary risk factor for ischaemic heart disease?" 37 : 1204-1208, 2008

      30 Kaufman FR, "Hypergonadotropic hypogonadism in female patients with galactosemia" 304 : 994-998, 1981

      31 Rubio-Gozalbo ME, "Gonadal function in male and female patients with classic galactosemia" 16 : 177-188, 2010

      32 Gibson JB, "Gonadal function in galactosemics and in galactose-intoxicated animals" 154 : S14-S20, 1995

      33 Koletzko B, "Global standard for the composition of infant formula: recommendations of an ESPGHAN coordinated international expert group" 41 : 584-599, 2005

      34 Xu YK, "Galactose metabolism in human ovarian tissue" 25 : 151-155, 1989

      35 Liu G, "Galactose metabolism and ovarian toxicity" 14 : 377-384, 2000

      36 Swartz WJ, "Galactose inhibition of ovulation in mice" 49 : 522-526, 1988

      37 Cooper GS, "Galactose consumption, metabolism, and follicle-stimulating hormone concentrations in women of late reproductive age" 62 : 1168-1175, 1994

      38 Cramer DW, "Galactose consumption and metabolism in relation to the risk of ovarian cancer" 2 : 66-71, 1989

      39 Fleckenstein A, "Excessive mural calcium overload-a predominant causal factor in the development of stenosing coronary plaques in humans" 4 : 1005-1013, 1990

      40 Segall JJ, "Epidemiological evidence for the link between dietary lactose and atherosclerosis, In The Glycation Hypothesis of Atherosclerosis" Champman & Hall 185-, 1997

      41 Cramer DW, "Epidemiologic aspects of early menopause and ovarian cancer" 592 : 363-375, 1990

      42 Lynch SM, "Effects of copper deficiency on hepatic and cardiac antioxidant enzyme activities in lactose- and sucrose-fed rats" 61 : 345-354, 1989

      43 Risch HA, "Dietary lactose intake, lactose intolerance, and the risk of epithelial ovarian cancer in southern Ontario (Canada)" 5 : 540-548, 1994

      44 Cramer DW, "Determinants of ovarian cancer risk. II. inferences regarding pathogenesis" 7 : 717-721, 1983

      45 Cramer DW, "Determinants of basal follicle-stimulating hormone levels in premenopausal women" 79 : 1105-1109, 1994

      46 Ng WG, "Deficit of uridine diphosphate galactose in galactosaemia" 12 : 257-266, 1989

      47 Bolton-Smith C, "Coronary heart disease: prevalence and dietary sugars in Scotland" 48 : 119-122, 1994

      48 Al-Delaimy WK, "Commentary: Lactose and ischaemic heart disease: a weak 28-year-old hypothesis" 37 : 1214-1216, 2008

      49 Til HP, "Chronic (89-week) feeding study with hydroxypropyl distarch phosphate, starch acetate, lactose and sodium alginate in mice" 24 : 825-834, 1986

      50 Cramer DW, "Characteristics of women with a family history of ovarian cancer. I. Galactose consumption and metabolism" 74 : 1309-1317, 1994

      51 Pomare EW, "Carbohydrate fermentation in the human colon and its relation to acetate concentrations in venous blood" 75 : 1448-1454, 1985

      52 Prestoz LL, "Altered follicle stimulating hormone isoforms in female galactosaemia patients" 156 : 116-120, 1997

      53 Meyer WR, "Aldose reductase inhibition prevents galactose-induced ovarian dysfunction in the Sprague-Dawley rat" 167 : 1837-1843, 1992

      54 Hoverstad T, "Absorption of short-chain fatty acids from the human colon measured by the 14CO2 breath test" 17 : 373-378, 1982

      55 Baldrick P, "A toxicological review of lactose to support clinical administration by inhalation" 35 : 719-733, 1997

      56 Hodgkinson A, "A comparison of the effects of lactose and of two chemically modified waxy maize starches on mineral metabolism in the rats" 20 : 371-382, 1982

      57 Cramer DW, "A case-control study of galactose consumption and metabolism in relation to ovarian cancer" 9 : 95-101, 2000

      더보기

      동일학술지(권/호) 다른 논문

      동일학술지 더보기

      더보기

      분석정보

      View

      상세정보조회

      0

      Usage

      원문다운로드

      0

      대출신청

      0

      복사신청

      0

      EDDS신청

      0

      동일 주제 내 활용도 TOP

      더보기

      주제

      연도별 연구동향

      연도별 활용동향

      연관논문

      연구자 네트워크맵

      공동연구자 (7)

      유사연구자 (20) 활용도상위20명

      인용정보 인용지수 설명보기

      학술지 이력

      학술지 이력
      연월일 이력구분 이력상세 등재구분
      2022 평가예정 계속평가 신청대상 (계속평가)
      2021-12-01 평가 등재후보로 하락 (재인증) KCI등재후보
      2018-01-01 평가 등재학술지 유지 (등재유지) KCI등재
      2016-01-04 학술지명변경 한글명 : Journal of Biomedical Research -> Journal of Biomedical and Translational Research
      외국어명 : Journal of Biomedical Research -> Journal of Biomedical and Translational Research
      KCI등재
      2015-01-01 평가 등재학술지 선정 (계속평가) KCI등재
      2013-01-01 평가 등재후보학술지 유지 (기타) KCI등재후보
      2011-01-01 평가 등재후보학술지 선정 (신규평가) KCI등재후보
      더보기

      학술지 인용정보

      학술지 인용정보
      기준연도 WOS-KCI 통합IF(2년) KCIF(2년) KCIF(3년)
      2016 0.03 0.03 0.07
      KCIF(4년) KCIF(5년) 중심성지수(3년) 즉시성지수
      0.08 0.07 0.306 0.04
      더보기

      이 자료와 함께 이용한 RISS 자료

      나만을 위한 추천자료

      해외이동버튼